Urology Cancer Center and GU Research Network — Omaha, Nebraska

Urology Cancer Center and GU Research Network is a clinical research site located in Omaha, Nebraska, United States.

Crixeo Clinical Trials Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Urology Cancer Center and GU Research Network has participated in 9 clinical trials.

Therapeutic areas: Prostate Cancer, Urologic Neoplasms, Metastatic Bladder Cancer.

Sponsors: Achieve Life Sciences, Memorial Sloan Kettering Cancer Center, LTN PHARMACEUTICALS, INC..

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Urology Cancer Center and GU Research Network?

Urology Cancer Center and GU Research Network has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Urology Cancer Center and GU Research Network conducted?

Urology Cancer Center and GU Research Network has 9 clinical trials on record. Their work covers Prostate Cancer, Urologic Neoplasms, Metastatic Bladder Cancer.

Is Urology Cancer Center and GU Research Network accredited by Crixeo Clinical Trials?

Urology Cancer Center and GU Research Network has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Urology Cancer Center and GU Research Network?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.